Evaluation of Methionine Content in a High-Fat and Choline-Deficient Diet on Body Weight Gain and the Development of Non-Alcoholic Steatohepatitis in Mice

PLoS One. 2016 Oct 10;11(10):e0164191. doi: 10.1371/journal.pone.0164191. eCollection 2016.

Abstract

Aim: Non-alcoholic steatohepatitis (NASH) is a globally recognized liver disease. A methionine- and choline-deficient diet is used to induce NASH in mice; however, this diet also causes severe body weight loss. To resolve this issue, we examined the effects of methionine content in a high-fat and choline-deficient (HFCD) diet on body weight and the development of NASH in mice.

Methods: C57BL/6J mice (male, 10 weeks of age) were fed an L-amino acid rodent (control) diet, high-fat (HF) diet, or HFCD diet containing various amounts of methionine (0.1-0.6% (w/w)) for 12 weeks. Plasma lipid levels, hepatic lipid content and inflammatory marker gene expression were measured, and a pathological analysis was conducted to evaluate NASH.

Results: The 0.1% methionine in HFCD diet suppressed body weight gain, which was lower than that with control diet. On the other hand, the 0.2% methionine in HFCD diet yielded similar body weight gains as the control diet, while more than 0.4% methionine showed the same body weight gains as the HF diet. Liver weights and hepatic lipid contents were the greatest with 0.1% methionine and decreased in a methionine dose-dependent manner. Pathological analysis, NAFLD activity scores and gene expression levels in the liver revealed that 0.1% and 0.2% methionine for 12 weeks induced NASH, whereas 0.4% and 0.6% methionine attenuated the induction of NASH by HFCD diet. However, the 0.2% methionine in HFCD diet did not induce insulin resistance, despite the body weight gain.

Conclusions: The 0.2% methionine in HFCD diet for 12 weeks was able to induce NASH without weight loss.

MeSH terms

  • Animals
  • Biomarkers / blood
  • Choline / metabolism
  • Choline / pharmacology
  • Diet, High-Fat*
  • Fibrosis
  • Gene Expression / drug effects
  • Glucose Tolerance Test
  • Lipids / analysis
  • Liver / metabolism
  • Liver / pathology
  • Male
  • Methionine / pharmacology*
  • Mice
  • Mice, Inbred C57BL
  • Non-alcoholic Fatty Liver Disease / pathology*
  • Time Factors
  • Weight Gain / drug effects*

Substances

  • Biomarkers
  • Lipids
  • Methionine
  • Choline

Grants and funding

The authors received no specific funding for this work.